Azithromycin Cas nhamba: 83905-01-5 Molecular Formula: C38H72N2O12

Tsanangudzo Pfupi:

Cas nhamba: 83905-01-5

Kemikari Zita: Azithromycin

Molecular Formula:C38H72N2O12

Anoreva zvakafanana:(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R) -13- [(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L- ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-( dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one

Tumira email kwatiri

Product Detail

Product Tags

Products Specification

Melting Point	115°C
Density	1.18 g/cm³
kuchengetedza temp	Mamiriro ekunze akadzikama, Tembiricha yemumba 2-8°C
solubility	DMF: 16 mg/ml DMSO: 5 mg/mlm Ethanol: 16 mg/ml Ethanol:PBS(pH 7.2) (1:1): 0.50 mg/ml
optical chiitiko	N/A
Chitarisiko	White Powder
Kuchena	≥98%

Tsanangudzo

Manus Aktteva Biopharma LLP, kambani yeGlobal sourcing uye mutengesi weAzithromycin (CAS Nha.: 83905-01-5) inopa kune zvaunoda zveRND / Development uwandu kana kushambadzira, zvichienderana nechimiro chechigadzirwa.

ZVINOTAURWA : Nepo kungwarira kwese kwakafanira kuchigoneka kuchizoitwa uye isu tichabatana pazvinhu zvese kana paine dambudziko rikamuka panguva yekutsvagirwa, isu hatigone kuve nemhosva yekusateedzera kana kuomesesa mukutengeserana kungaitika, izvo zvatisingakwanisi kudzora.Zvigadzirwa zvinodonha muchikamu chemishonga inodzorwa / runyorwa rwemishonga inorongwa ichatengeswa kunze kwenyika zvakananga kubva kuvakuru vevagadziri chete kana yawana mvumo yekutenga kubva kune dzimwe nyika yakapihwa nevakuru vane chekuita nenyika inopinza.• Ndapota zivai kuti tiri kushanda nemutemo uzere uye hatityora chero mitemo mudunhu kana pasi rose.Marekodhi edu eruzhinji anotaura nezve kuvimbika kwedu.Isu hatikurudzire kana kuda kuve chikamu chechero masangano akazvimirira kana eruzhinji kuratidza kutevedzera kwedu.

PATENTS Zvigadzirwa zvakadzivirirwa nematendi anoshanda hazvipihwe kutengeswa munyika umo kutengeswa kwezvinhu zvakadaro kunokanganisa patent uye mhosva yacho iri panjodzi yemutengi.Zvigadzirwa parizvino zvakavharwa neUS Patents anoshanda zvinopihwa kuti zvishandiswe neR&D zvinoenderana ne35 USC 271 +A13(1)•Manus Aktteva Biopharma LLP haatore mutoro kana mhosva yekupihwa zvinhu zvinokanganisa hunyanzvi hwekuziva chero nzira ipi zvayo inosanganisira. patent kodzero dzemunhu chero upi zvake.Manus Aktteva Biopharma LLP haaite zvinomiririra kana waranti yechero rudzi, kutaura kana kurehwa, nezve kwekutanga kana kuvimbika maererano nenjere pfuma inosanganisira patent muzvigadzirwa zvayo kana masevhisi kune chero chinangwa.Manus Aktteva Biopharma LLP anoyambira vatengesi kuti vasatengese chero zvinhu zvinotyora pfuma yeruzivo nenzira ipi zvayo inosanganisira kodzero dzepatent yemunhu chero upi zvake.Manus Aktteva Biopharma LLP inoyambira vatengi kuti vasashandise kana kutenga chero zvinhu kuti vawane chigadzirwa chinogona kunge chiri kukonzera kukanganisa kwehungwaru chero nzira ipi zvayo inosanganisira kodzero dzepatent yechero munhu.

kushandiswa uye dosage

Azithromycin inonzi semi-synthetic, ring-expanded erythromycin yakagadzirwa neBeckmann rearrangement ye erythromycin oxime uye kuderedza kune imine ether, inoteverwa ne reductive methylation.Azithromycin yaive yekutanga yeazalides uye yakagadzirirwa kuvandudza kugadzikana uye biological hafu yeupenyu hweerythromycin A, pamwe nekuvandudza basa rekurwisa Gram negative bacteria.Kubva payakawanikwa muna 1980 naDjokic nevashandi pamwe chete, azithromycin yakanakidzwa nekubudirira kukuru kwekurapa.